SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001372514-24-000002
Filing Date
2024-01-16
Accepted
2024-01-16 17:16:29
Documents
12
Period of Report
2024-01-16
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K kprx-20240116.htm   iXBRL 8-K 24950
  Complete submission text file 0001372514-24-000002.txt   156520

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kprx-20240116.xsd EX-101.SCH 1919
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kprx-20240116_lab.xml EX-101.LAB 25852
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kprx-20240116_pre.xml EX-101.PRE 13593
6 EXTRACTED XBRL INSTANCE DOCUMENT kprx-20240116_htm.xml XML 2918
Mailing Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024
Business Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024 781-788-8869
KIORA PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36672 | Film No.: 24535997
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)